Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.023 | 0.9 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |